stoxline Quote Chart Rank Option Currency Glossary
  
Calyxt, Inc. (CLXT)
6.3  0.33 (5.53%)    05-31 16:00
Open: 6.16
High: 7.77
Volume: 254,088
  
Pre. Close: 5.97
Low: 6.01
Market Cap: 31(M)
Technical analysis
2023-08-04 4:27:17 PM
Short term     
Mid term     
Targets 6-month :  28.74 1-year :  33.57
Resists First :  24.61 Second :  28.74
Pivot price 18.09
Supports First :  14.9 Second :  8.89
MAs MA(5) :  20.68 MA(20) :  16.47
MA(100) :  17.9 MA(250) :  13.76
MACD MACD :  0.8 Signal :  0.4
%K %D K(14,3) :  64 D(3) :  73.8
RSI RSI(14): 49.8
52-week High :  32.7 Low :  6.01
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ CLXT ] has closed below upper band by 49.4%. Bollinger Bands are 51.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 19.81 - 19.95 19.95 - 20.05
Low: 17.2 - 17.37 17.37 - 17.5
Close: 17.95 - 18.18 18.18 - 18.37
Company Description

Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.

Headline News

Fri, 19 May 2023
Calyxt Announces Stockholder Approval of Merger With Cibus - PR Newswire

Tue, 18 Apr 2023
Calyxt, Inc. Announces Effectiveness of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC - Stock Titan

Fri, 07 Apr 2023
Calyxt Announces Effective Date of Reverse Stock Split - PR Newswire

Tue, 17 Jan 2023
Calyxt and Cibus Announce Definitive Merger Agreement to Create Industry-Leading Precision Gene Editing and Trait Licensing Company - PR Newswire

Tue, 25 Oct 2022
Calyxt Successfully Produces Plant-Based Squalene, an Important Ingredient in Personal Care Products and Critical Vaccine Adjuvants - PR Newswire

Tue, 15 Jun 2021
Roth Capital Partners to Virtually Host 7th Annual Roth London Conference on June 21-23, 2021 - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Consumer Defensive
Industry:
Packaged Foods
Shares Out 0 (M)
Shares Float 5 (M)
Held by Insiders 2.49e+006 (%)
Held by Institutions 49.9 (%)
Shares Short 37 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -1.909e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -12 %
Return on Assets (ttm) 421.5 %
Return on Equity (ttm) -44.3 %
Qtrly Rev. Growth 167000 %
Gross Profit (p.s.) 15.29
Sales Per Share -92.91
EBITDA (p.s.) 76960.8
Qtrly Earnings Growth -3.9 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -15 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.2
Price to Cash Flow 68.71
Stock Dividends
Dividend 0
Forward Dividend 118110
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android